Mehta, A. I., Persson, O., Herndon, J. E., Archer, G. E., McLendon, R., Heimberger, A. B., … Sampson, J. H. (2011). Reply to M.S. Lesniak. Journal of Clinical Oncology, 29(22), 3105–3106. https://doi.org/10.1200/JCO.2011.35.0256

Mehta, A. I., O. Persson, J. E. Herndon, G. E. Archer, R. McLendon, A. B. Heimberger, D. A. Mitchell, D. D. Bigner, and J. H. Sampson. “Reply to M.S. Lesniak.” Journal of Clinical Oncology 29, no. 22 (August 1, 2011): 3105–6. https://doi.org/10.1200/JCO.2011.35.0256.

Mehta AI, Persson O, Herndon JE, Archer GE, McLendon R, Heimberger AB, et al. Reply to M.S. Lesniak. Journal of Clinical Oncology. 2011 Aug 1;29(22):3105–6.

Mehta, A. I., et al. “Reply to M.S. Lesniak.” Journal of Clinical Oncology, vol. 29, no. 22, Aug. 2011, pp. 3105–06. Scopus, doi:10.1200/JCO.2011.35.0256.

Mehta AI, Persson O, Herndon JE, Archer GE, McLendon R, Heimberger AB, Mitchell DA, Bigner DD, Sampson JH. Reply to M.S. Lesniak. Journal of Clinical Oncology. 2011 Aug 1;29(22):3105–3106.